Skip to main content

Neumora Therapeutics, Inc.

NMRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001885522

In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Neumora Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
1 insider, $701.6K in total
Insiders trading
1
Net value
−$701.6K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Neumora Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Neumora Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Aurora Daljit SinghSee Remarks0IndirectAug 21, 20265
Berns Paul LSee Remarks7,395,185Aug 21, 20263
Duncan JasonSee Remarks–Aug 21, 20262
Milligan Michael LeeSee Remarks21,034Aug 21, 20263
Pinto JoshuaPresident & CEO57,783Aug 21, 20263
Fust Matthew KDirector20,100May 29, 20261
Burow KristinaDirector, 10% Owner6,046,907IndirectMay 29, 20262
Piacquad DavidDirector20,100May 29, 20261
Ho MaykinDirector20,100May 29, 20261
Halawa AlaaDirector20,100May 29, 20261
Crandell Keith10% Owner6,046,907IndirectOct 29, 20251
Nelsen Robert10% Owner6,046,907IndirectOct 29, 20251
Bybee Clinton10% Owner6,046,907IndirectOct 29, 20251
Gillis Steven10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Fund XII, L.P.10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Partners XII, LLC10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Partners XII, L.P.10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Fund VII, L.P.10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Partners VII, LLC10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Partners VII, L.P.10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Partners VIII, LLC10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Fund VIII Overage, L.P.10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Fund X, L.P.10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Fund X Overage, L.P.10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Partners X Overage, L.P.10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Partners X, LLC10% Owner6,046,907IndirectOct 29, 20251
ARCH Venture Partners X, L.P.10% Owner6,046,907IndirectOct 29, 20251
Lenz Robert A.Head of R&D309,092Feb 20, 20250
Gosebruch Henry OPresident & CEO462,345Feb 16, 20240
Suh Carol Y.Chief Operating Officer374,674Feb 16, 20240
FMR LLCOther: See Remark 188,289IndirectSep 21, 20230
Amgen Inc10% Owner35,368,653Sep 19, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 21, 2026 (view filing)7:10 PM ETAug 20-211 dayAurora Daljit SinghSee RemarksSSale−88.3K$1.53−$135.4K−64.4%48.8K after2 lots
Aug 21, 2026 (view filing)7:10 PM ETAug 20-211 dayAurora Daljit SinghSee RemarksSSale−87.8K$1.53−$134.6K−100.0%0 after2 lots
Aug 19, 2026 (view filing)7:17 PM ETAug 17-192 daysAurora Daljit SinghSee RemarksSSale−156.9K$1.55−$242.5K−76.3%48.8K after4 lots
Aug 19, 2026 (view filing)7:17 PM ETAug 17-192 daysAurora Daljit SinghSee RemarksSSale−120.9K$1.56−$189.2K−100.0%0 after3 lots
Feb 19, 2026 (view filing)Feb 172 daysAurora Daljit SinghSee RemarksSSale−6.17K$3.56−$21.9K−6.9%82.8K after
Feb 19, 2026 (view filing)Feb 172 daysPinto JoshuaPresidentSSale−5.97K$3.54−$21.1K−9.4%57.8K after
Feb 19, 2026 (view filing)Feb 172 daysBerns Paul LSee RemarksSSale−9.82K$3.51−$34.5K−0.1%7.40M after
Feb 19, 2026 (view filing)Feb 172 daysMilligan Michael LeeSee RemarksSSale−1.44K$3.57−$5.13K−6.4%21.0K after10b5-1
Nov 13, 2025 (view filing)Nov 112 daysAurora Daljit SinghSee RemarksSSale−114.7K$2.68−$307.4K−100.0%0 after10b5-1
Oct 29, 2025 (view filing)7:21 PM ETOct 272 daysCrandell Keith and 6 others10% OwnerPPurchase+1.92M$2.61+$5.00M+46.4%6.05M afterDuplicate filing
Oct 29, 2025 (view filing)7:19 PM ETOct 272 daysARCH Venture Fund VII, L.P. and 9 others10% OwnerPPurchase+1.92M$2.61+$5.00M+46.4%6.05M afterDuplicate filing
Oct 29, 2025 (view filing)Oct 272 daysBurow KristinaDirector, 10% OwnerPPurchase+1.92M$2.61+$5.00M+46.4%6.05M after
Feb 20, 2025 (view filing)Feb 182 daysBerns Paul LSee RemarksSSale−13.9K$1.69−$23.4K−0.2%7.41M after10b5-1
Feb 20, 2025 (view filing)Feb 182 daysMilligan Michael LeeSee RemarksSSale−1.98K$1.69−$3.34K−8.1%22.5K after10b5-1
Feb 20, 2025 (view filing)Feb 182 daysAurora Daljit SinghChief Strategy OfficerSSale−8.56K$1.68−$14.4K−8.8%88.9K after10b5-1
Feb 20, 2025 (view filing)Feb 182 daysLenz Robert A.Head of R&DSSale−5.61K$1.67−$9.38K−1.8%309.1K after10b5-1
Feb 20, 2025 (view filing)Feb 182 daysPinto JoshuaPresidentSSale−8.05K$1.67−$13.4K−9.5%77.0K after10b5-1
Oct 18, 2024 (view filing)Oct 17-181 dayFust Matthew KDirectorSSale−21.8K$17.02−$370.9K−52.0%20.1K after2 lots10b5-1
Oct 11, 2024 (view filing)Oct 9-102 daysLenz Robert A.Head of R&DSSale−13.8K$15.06−$208.1K−4.2%314.7K after2 lots10b5-1
Sep 19, 2024 (view filing)Sep 17-182 daysLenz Robert A.Head of R&DSSale−41.5K$11.88−$492.7K−11.2%328.5K after2 lots10b5-1
Sep 16, 2024 (view filing)Sep 124 daysLenz Robert A.Head of R&DSSale−32.9K$11.43−$376.6K−8.2%370.0K after10b5-1
Aug 27, 2024 (view filing)Aug 27Same dayPinto JoshuaChief Financial OfficerSSale−15.7K$11.39−$178.7K−10.1%139.0K after10b5-1
Aug 26, 2024 (view filing)Aug 22-264 daysPinto JoshuaChief Financial OfficerSSale−84.3K$11.67−$984.3K−35.3%154.7K after3 lots10b5-1
Nov 15, 2023 (view filing)6:54 PM ETNov 13-142 daysCrandell Keith and 5 others10% OwnerPPurchase+35.0K$11.77+$412.1K+0.9%4.13M after2 lotsDuplicate filing
Nov 15, 2023 (view filing)Nov 13-142 daysBurow KristinaDirector, 10% OwnerPPurchase+35.0K$11.77+$412.1K+0.9%4.13M after2 lots
Nov 13, 2023 (view filing)7:00 PM ETNov 8-105 daysCrandell Keith and 5 others10% OwnerPPurchase+140.6K$10.98+$1.54M+3.6%4.10M after5 lotsDuplicate filing
Nov 13, 2023 (view filing)Nov 8-105 daysBurow KristinaDirector, 10% OwnerPPurchase+140.6K$10.98+$1.54M+3.6%4.10M after5 lots
Nov 7, 2023 (view filing)6:59 PM ETNov 3-74 daysCrandell Keith and 5 others10% OwnerPPurchase+95.7K$11.49+$1.10M+2.5%3.96M after3 lotsDuplicate filing
Nov 7, 2023 (view filing)Nov 3-74 daysBurow KristinaDirector, 10% OwnerPPurchase+95.7K$11.49+$1.10M+2.5%3.96M after3 lots
Sep 29, 2023 (view filing)6:53 PM ETSep 28-291 dayCrandell Keith and 5 others10% OwnerPPurchase+76.5K$13.68+$1.05M+2.0%3.86M after3 lotsDuplicate filing
Sep 29, 2023 (view filing)Sep 28-291 dayBurow KristinaDirector, 10% OwnerPPurchase+76.5K$13.68+$1.05M+2.0%3.86M after3 lots
Sep 27, 2023 (view filing)8:18 PM ETSep 26-271 dayCrandell Keith and 5 others10% OwnerPPurchase+58.5K$11.97+$700.5K+1.6%3.78M after2 lotsDuplicate filing
Sep 27, 2023 (view filing)Sep 26-271 dayBurow KristinaDirector, 10% OwnerPPurchase+58.5K$11.97+$700.5K+1.6%3.78M after2 lots
Sep 25, 2023 (view filing)9:38 PM ETSep 22-253 daysCrandell Keith and 5 others10% OwnerPPurchase+100.7K$11.19+$1.13M+2.8%3.72M after3 lotsDuplicate filing
Sep 25, 2023 (view filing)Sep 22-253 daysBurow KristinaDirector, 10% OwnerPPurchase+100.7K$11.19+$1.13M+2.8%3.72M after3 lots
Sep 20, 2023 (view filing)6:16 AM ETSep 191 dayCrandell Keith and 7 others10% OwnerPPurchase+1.50M$17.00+$25.5M+70.6%3.62M afterDuplicate filing
Sep 20, 2023 (view filing)6:15 AM ETSep 191 dayARCH Venture Fund VII, L.P. and 9 others10% OwnerPPurchase+1.50M$17.00+$25.5M+70.6%3.62M afterDuplicate filing
Sep 20, 2023 (view filing)Sep 191 dayBurow KristinaDirector, 10% OwnerPPurchase+1.50M$17.00+$25.5M+70.6%3.62M after
Sep 19, 2023 (view filing)Sep 19Same dayGosebruch Henry OPresident & CEOPPurchase+15.0K$12.62+$189.3KNew position15.0K after
Sep 19, 2023 (view filing)Sep 19Same dayAmgen Inc10% OwnerPPurchase+1.76M$17.00+$30.0M+5.3%35.4M after